{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:54:57Z","timestamp":1794664497113,"version":"4.9.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T00:00:00Z","timestamp":1755734400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Parkinson\u2019s disease (PD), a progressive neurodegenerative disorder, presents complex motor symptoms and lacks effective disease-modifying treatments. Here we show that integrating artificial intelligence (AI) with optogenetic intervention, termed optoRET, modulating c-RET (REarranged during Transfection) signalling, enables task-independent behavioural assessments and therapeutic benefits in freely moving male AAV-hA53T mice. Utilising a 3D pose estimation technique, we developed tree-based AI models that detect PD severity cohorts earlier and with higher accuracy than conventional methods. Employing an explainable AI technique, we identified a comprehensive array of PD behavioural markers, encompassing gait and spectro-temporal features. Moreover, our AI-driven analysis highlights that optoRET effectively alleviates PD progression by improving limb coordination and locomotion and reducing chest tremor. Our study demonstrates the synergy of integrating AI and optogenetic techniques to provide an efficient diagnostic method with extensive behavioural evaluations and sets the stage for an innovative treatment strategy for PD.<\/jats:p>","DOI":"10.1038\/s41467-025-63025-w","type":"journal-article","created":{"date-parts":[[2025,8,21]],"date-time":"2025-08-21T12:18:05Z","timestamp":1755778685000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Integrating artificial intelligence and optogenetics for Parkinson\u2019s disease diagnosis and therapeutics in male mice"],"prefix":"10.1038","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1006-4777","authenticated-orcid":false,"given":"Bobae","family":"Hyeon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1056-7102","authenticated-orcid":false,"given":"Jaehyun","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2317-9958","authenticated-orcid":false,"given":"Jae-Hun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woori","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4318-4383","authenticated-orcid":false,"given":"Jea","family":"Kwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heeyoung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae-gun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0674-7215","authenticated-orcid":false,"given":"Choong Yeon","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-6953-6200","authenticated-orcid":false,"given":"Sian","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7607-5453","authenticated-orcid":false,"given":"Jae-Woong","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6081-9857","authenticated-orcid":false,"given":"Kwang-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3555-0980","authenticated-orcid":false,"given":"C. Justin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9915-1463","authenticated-orcid":false,"given":"Daesoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7541-7319","authenticated-orcid":false,"given":"Won Do","family":"Heo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,21]]},"reference":[{"key":"63025_CR1","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1001\/jama.2019.22360","volume":"323","author":"MJ Armstrong","year":"2020","unstructured":"Armstrong, M. J. & Okun, M. S. Diagnosis and treatment of Parkinson disease: a review. JAMA 323, 548\u2013560 (2020).","journal-title":"JAMA"},{"key":"63025_CR2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s40035-023-00368-8","volume":"12","author":"A Dovonou","year":"2023","unstructured":"Dovonou, A. et al. Animal models of Parkinson\u2019s disease: bridging the gap between disease hallmarks and research questions. Trans. l Neurodegener. 12, 36 (2023).","journal-title":"Trans. l Neurodegener."},{"key":"63025_CR3","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1038\/s41591-022-01932-x","volume":"28","author":"Y Yang","year":"2022","unstructured":"Yang, Y. et al. Artificial intelligence-enabled detection and assessment of Parkinson\u2019s disease using nocturnal breathing signals. Nat. Med. 28, 2207\u20132215 (2022).","journal-title":"Nat. Med."},{"key":"63025_CR4","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s10020-021-00279-2","volume":"27","author":"T Ntetsika","year":"2021","unstructured":"Ntetsika, T., Papathoma, P. E. & Markaki, I. Novel targeted therapies for Parkinson\u2019s disease. Mol. Med 27, 17 (2021).","journal-title":"Mol. Med"},{"key":"63025_CR5","doi-asserted-by":"publisher","first-page":"693","DOI":"10.3389\/fnins.2018.00693","volume":"12","author":"TB Stoker","year":"2018","unstructured":"Stoker, T. B., Torsney, K. M. & Barker, R. A. Emerging treatment approaches for Parkinson\u2019s disease. Front Neurosci. 12, 693 (2018).","journal-title":"Front Neurosci."},{"key":"63025_CR6","doi-asserted-by":"publisher","first-page":"e2628","DOI":"10.1002\/brb3.2628","volume":"12","author":"A Aniszewska","year":"2022","unstructured":"Aniszewska, A., Bergstrom, J., Ingelsson, M. & Ekmark-Lewen, S. Modeling Parkinson\u2019s disease-related symptoms in alpha-synuclein overexpressing mice. Brain Behav. 12, e2628 (2022).","journal-title":"Brain Behav."},{"key":"63025_CR7","doi-asserted-by":"publisher","first-page":"875","DOI":"10.3233\/JPD-202004","volume":"10","author":"RA Barker","year":"2020","unstructured":"Barker, R. A. et al. GDNF and Parkinson\u2019s disease: where next? a summary from a recent workshop. J. Parkinsons Dis. 10, 875\u2013891 (2020).","journal-title":"J. Parkinsons Dis."},{"key":"63025_CR8","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.4103\/1673-5374.327330","volume":"17","author":"JA Conway","year":"2022","unstructured":"Conway, J. A. & Kramer, E. R. Is activation of GDNF\/RET signaling the answer for successful treatment of Parkinson\u2019s disease? A discussion of data from the culture dish to the clinic. Neural Regener. Res. 17, 1462\u20131467 (2022).","journal-title":"Neural Regener. Res."},{"key":"63025_CR9","doi-asserted-by":"publisher","first-page":"110231","DOI":"10.1016\/j.celrep.2021.110231","volume":"38","author":"K Sheppard","year":"2022","unstructured":"Sheppard, K. et al. Stride-level analysis of mouse open field behavior using deep-learning-based pose estimation. Cell Rep. 38, 110231 (2022).","journal-title":"Cell Rep."},{"key":"63025_CR10","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41386-020-0751-7","volume":"46","author":"L von Ziegler","year":"2021","unstructured":"von Ziegler, L., Sturman, O. & Bohacek, J. Big behavior: challenges and opportunities in a new era of deep behavior profiling. Neuropsychopharmacology 46, 33\u201344 (2021).","journal-title":"Neuropsychopharmacology"},{"key":"63025_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22970-y","volume":"12","author":"K Huang","year":"2021","unstructured":"Huang, K. et al. A hierarchical 3D-motion learning framework for animal spontaneous behavior mapping. Nat. Commun. 12, 2784 (2021).","journal-title":"Nat. Commun."},{"key":"63025_CR12","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1038\/nbt.1927","volume":"29","author":"D Hockemeyer","year":"2011","unstructured":"Hockemeyer, D. et al. Genetic engineering of human pluripotent cells using TALE nucleases. Nat. Biotechnol. 29, 731\u2013734 (2011).","journal-title":"Nat. Biotechnol."},{"key":"63025_CR13","doi-asserted-by":"publisher","unstructured":"Kim, D.-G., Shin, A., Jeong, Y.-C., Park, S. & Kim, D. AVATAR: AI vision analysis for three-dimensional action in real-time. https:\/\/doi.org\/10.1101\/2021.12.31.474634. bioRxiv (2022).","DOI":"10.1101\/2021.12.31.474634"},{"key":"63025_CR14","doi-asserted-by":"publisher","first-page":"119","DOI":"10.5607\/en24008","volume":"33","author":"J Kwon","year":"2024","unstructured":"Kwon, J., Sa, M., Kim, H., Seong, Y. & Lee, C. J. Egocentric 3D skeleton learning in a deep neural network encodes obese-like motion representations. Exp. Neurobiol. 33, 119\u2013128 (2024).","journal-title":"Exp. Neurobiol."},{"key":"63025_CR15","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1080\/01677063.2023.2174982","volume":"37","author":"J Kim","year":"2023","unstructured":"Kim, J., Kim, D. G., Jung, W. & Suh, G. S. B. Evaluation of mouse behavioral responses to nutritive versus nonnutritive sugar using a deep learning-based 3D real-time pose estimation system. J. Neurogenet. 37, 78\u201383 (2023).","journal-title":"J. Neurogenet."},{"key":"63025_CR16","doi-asserted-by":"crossref","unstructured":"Kwon, J. et al. SUBTLE: an unsupervised platform with temporal link embedding that maps animal behavior. Int. J. Comput. Vis. 132, 4589\u20134615 (2024).","DOI":"10.1007\/s11263-024-02072-0"},{"key":"63025_CR17","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2016.263","volume":"7","author":"A Drinkut","year":"2016","unstructured":"Drinkut, A. et al. Ret is essential to mediate GDNF\u2019s neuroprotective and neuroregenerative effect in a Parkinson disease mouse model. Cell Death Dis. 7, e2359 (2016).","journal-title":"Cell Death Dis."},{"key":"63025_CR18","doi-asserted-by":"publisher","first-page":"e39","DOI":"10.1371\/journal.pbio.0050039","volume":"5","author":"RGM Morris","year":"2007","unstructured":"Morris, R. G. M. et al. Absence of ret signaling in mice causes progressive and late degeneration of the nigrostriatal system. PLoS Biol. 5, e39 (2007).","journal-title":"PLoS Biol."},{"key":"63025_CR19","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1242\/dev.126.12.2785","volume":"126","author":"S Taraviras","year":"1999","unstructured":"Taraviras, S. et al. Signalling by the RET receptor tyrosine kinase and its role in the development of the mammalian enteric nervous system. Development 126, 2785\u20132797 (1999).","journal-title":"Development"},{"key":"63025_CR20","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1172\/JCI79300","volume":"125","author":"DP Meka","year":"2015","unstructured":"Meka, D. P. et al. Parkin cooperates with GDNF\/RET signaling to prevent dopaminergic neuron degeneration. J. Clin. Invest 125, 1873\u20131885 (2015).","journal-title":"J. Clin. Invest"},{"key":"63025_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s13041-023-01046-6","volume":"16","author":"B Hyeon","year":"2023","unstructured":"Hyeon, B., Lee, H., Kim, N. & Heo, W. D. Optogenetic dissection of RET signaling reveals robust activation of ERK and enhanced filopodia-like protrusions of regenerating axons. Mol. Brain 16, 56 (2023).","journal-title":"Mol. Brain"},{"key":"63025_CR22","doi-asserted-by":"publisher","first-page":"103684","DOI":"10.1016\/j.mcn.2021.103684","volume":"118","author":"V Mesa-Infante","year":"2022","unstructured":"Mesa-Infante, V., Afonso-Oramas, D., Salas-Hernandez, J., Rodriguez-Nunez, J. & Barroso-Chinea, P. Long-term exposure to GDNF induces dephosphorylation of Ret, AKT, and ERK1\/2, and is ineffective at protecting midbrain dopaminergic neurons in cellular models of Parkinson\u2019s disease. Mol. Cell Neurosci. 118, 103684 (2022).","journal-title":"Mol. Cell Neurosci."},{"key":"63025_CR23","doi-asserted-by":"publisher","first-page":"101106","DOI":"10.1016\/j.omtm.2023.09.002","volume":"31","author":"MD Azevedo","year":"2023","unstructured":"Azevedo, M. D. et al. Oxidative stress induced by sustained supraphysiological intrastriatal GDNF delivery is prevented by dose regulation. Mol. Ther. Methods Clin. Dev. 31, 101106 (2023).","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"63025_CR24","doi-asserted-by":"publisher","first-page":"163ra156","DOI":"10.1126\/scitranslmed.3004676","volume":"4","author":"M Decressac","year":"2012","unstructured":"Decressac, M. et al. alpha-Synuclein-induced down-regulation of Nurr1 disrupts GDNF signaling in nigral dopamine neurons. Sci. Transl. Med 4, 163ra156 (2012).","journal-title":"Sci. Transl. Med"},{"key":"63025_CR25","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneurol.2013.209","volume":"9","author":"M Decressac","year":"2013","unstructured":"Decressac, M., Volakakis, N., Bjorklund, A. & Perlmann, T. NURR1 in Parkinson disease\u2014from pathogenesis to therapeutic potential. Nat. Rev. Neurol. 9, 629\u2013636 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"63025_CR26","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1002\/mds.28258","volume":"35","author":"P Chmielarz","year":"2020","unstructured":"Chmielarz, P. et al. GDNF\/RET signaling pathway activation eliminates lewy body pathology in midbrain dopamine neurons. Mov. Disord. 35, 2279\u20132289 (2020).","journal-title":"Mov. Disord."},{"key":"63025_CR27","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1021\/acschemneuro.8b00579","volume":"10","author":"VC Ruf","year":"2019","unstructured":"Ruf, V. C. et al. Different effects of alpha-synuclein mutants on lipid binding and aggregation detected by single molecule fluorescence spectroscopy and ThT fluorescence-based measurements. ACS Chem. Neurosci. 10, 1649\u20131659 (2019).","journal-title":"ACS Chem. Neurosci."},{"key":"63025_CR28","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s40478-017-0416-x","volume":"5","author":"CW Ip","year":"2017","unstructured":"Ip, C. W. et al. AAV1\/2-induced overexpression of A53T-alpha-synuclein in the substantia nigra results in degeneration of the nigrostriatal system with Lewy-like pathology and motor impairment: a new mouse model for Parkinson\u2019s disease. Acta Neuropathol. Commun. 5, 11 (2017).","journal-title":"Acta Neuropathol. Commun."},{"key":"63025_CR29","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-54034-z","volume":"9","author":"T Kilpelainen","year":"2019","unstructured":"Kilpelainen, T., Julku, U. H., Svarcbahs, R. & Myohanen, T. T. Behavioural and dopaminergic changes in double mutated human A30P*A53T alpha-synuclein transgenic mouse model of Parkinsons disease. Sci. Rep. 9, 17382 (2019).","journal-title":"Sci. Rep."},{"key":"63025_CR30","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.nbd.2005.08.005","volume":"21","author":"EL Unger","year":"2006","unstructured":"Unger, E. L. et al. Locomotor hyperactivity and alterations in dopamine neurotransmission are associated with overexpression of A53T mutant human alpha-synuclein in mice. Neurobiol. Dis. 21, 431\u2013443 (2006).","journal-title":"Neurobiol. Dis."},{"key":"63025_CR31","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1186\/s13024-020-00380-w","volume":"15","author":"N Landeck","year":"2020","unstructured":"Landeck, N. et al. Two C-terminal sequence variations determine differential neurotoxicity between human and mouse alpha-synuclein. Mol. Neurodegener. 15, 49 (2020).","journal-title":"Mol. Neurodegener."},{"key":"63025_CR32","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1038\/nn.4529","volume":"20","author":"T Logan","year":"2017","unstructured":"Logan, T., Bendor, J., Toupin, C., Thorn, K. & Edwards, R. H. alpha-Synuclein promotes dilation of the exocytotic fusion pore. Nat. Neurosci. 20, 681\u2013689 (2017).","journal-title":"Nat. Neurosci."},{"key":"63025_CR33","doi-asserted-by":"publisher","first-page":"3760","DOI":"10.1016\/j.febslet.2015.11.006","volume":"589","author":"ER Kramer","year":"2015","unstructured":"Kramer, E. R. & Liss, B. GDNF-Ret signaling in midbrain dopaminergic neurons and its implication for Parkinson disease. FEBS Lett. 589, 3760\u20133772 (2015).","journal-title":"FEBS Lett."},{"key":"63025_CR34","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s13311-012-0104-2","volume":"9","author":"MF Chesselet","year":"2012","unstructured":"Chesselet, M. F. et al. A progressive mouse model of Parkinson\u2019s disease: the Thy1-aSyn (\u201cLine 61\u201d) mice. Neurotherapeutics 9, 297\u2013314 (2012).","journal-title":"Neurotherapeutics"},{"key":"63025_CR35","doi-asserted-by":"publisher","first-page":"1462041","DOI":"10.3389\/fnins.2024.1462041","volume":"18","author":"L Breznik","year":"2024","unstructured":"Breznik, L. et al. Motor deficits and brain pathology in the Parkinson\u2019s disease mouse model hA53Ttg. Front Neurosci. 18, 1462041 (2024).","journal-title":"Front Neurosci."},{"key":"63025_CR36","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1002\/dvg.20228","volume":"44","author":"CM B\u00e4ckman","year":"2006","unstructured":"B\u00e4ckman, C. M. et al. Characterization of a mouse strain expressing Cre recombinase from the 3\u2032 untranslated region of the dopamine transporter locus. Genesis 44, 383\u2013390 (2006).","journal-title":"Genesis"},{"key":"63025_CR37","doi-asserted-by":"publisher","DOI":"10.1186\/1750-1326-5-43","volume":"5","author":"JB Koprich","year":"2010","unstructured":"Koprich, J. B., Johnston, T. H., Reyes, M. G., Sun, X. & Brotchie, J. M. Expression of human A53T alpha-synuclein in the rat substantia nigra using a novel AAV1\/2 vector produces a rapidly evolving pathology with protein aggregation, dystrophic neurite architecture and nigrostriatal degeneration with potential to model the pat. Mol. Neurodegener. 5, 43 (2010).","journal-title":"Mol. Neurodegener."},{"key":"63025_CR38","doi-asserted-by":"publisher","first-page":"e8784","DOI":"10.1371\/journal.pone.0008784","volume":"5","author":"V Sanchez-Guajardo","year":"2010","unstructured":"Sanchez-Guajardo, V., Febbraro, F., Kirik, D. & Romero-Ramos, M. Microglia acquire distinct activation profiles depending on the degree of alpha-synuclein neuropathology in a rAAV based model of Parkinson\u2019s disease. PLoS One 5, e8784 (2010).","journal-title":"PLoS One"},{"key":"63025_CR39","unstructured":"Ali, M. PyCaret: an open source, low-code machine learning library in Python. GitHub repository, PyCaret version 1.0.0 https:\/\/github.com\/pycaret\/pycaret (2020)."},{"key":"63025_CR40","doi-asserted-by":"publisher","first-page":"3155","DOI":"10.1073\/pnas.93.7.3155","volume":"93","author":"PH Tu","year":"1996","unstructured":"Tu, P. H. et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA 93, 3155\u20133160 (1996).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63025_CR41","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","volume":"23","author":"J Blesa","year":"2022","unstructured":"Blesa, J., Foffani, G., Dehay, B., Bezard, E. & Obeso, J. A. Motor and non-motor circuit disturbances in early Parkinson disease: which happens first? Nat. Rev. Neurosci. 23, 115\u2013128 (2022).","journal-title":"Nat. Rev. Neurosci."},{"key":"63025_CR42","first-page":"6785","volume":"30","author":"SM Lundberg","year":"2017","unstructured":"Lundberg, S. M. & Su-In Lee, A. Unified approach to interpreting model predictions. Adv. Neural Inf. Process. Syst. 30, 6785\u20136795 (2017).","journal-title":"Adv. Neural Inf. Process. Syst."},{"key":"63025_CR43","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1038\/s42256-019-0138-9","volume":"2","author":"SM Lundberg","year":"2020","unstructured":"Lundberg, S. M. et al. From local explanations to global understanding with explainable AI for trees. Nat. Mach. Intell. 2, 56\u201367 (2020).","journal-title":"Nat. Mach. Intell."},{"key":"63025_CR44","doi-asserted-by":"publisher","first-page":"e1009479","DOI":"10.1371\/journal.pgen.1009479","volume":"17","author":"A Ingles-Prieto","year":"2021","unstructured":"Ingles-Prieto, A. et al. Optogenetic delivery of trophic signals in a genetic model of Parkinson\u2019s disease. PLoS Genet 17, e1009479 (2021).","journal-title":"PLoS Genet"},{"key":"63025_CR45","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41551-021-00814-w","volume":"6","author":"R Qazi","year":"2022","unstructured":"Qazi, R. et al. Scalable and modular wireless-network infrastructure for large-scale behavioural neuroscience. Nat. Biomed. Eng. 6, 771\u2013786 (2022).","journal-title":"Nat. Biomed. Eng."},{"key":"63025_CR46","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-39970-9","volume":"14","author":"W Kim","year":"2023","unstructured":"Kim, W. et al. An optimized Nurr1 agonist provides disease-modifying effects in Parkinson\u2019s disease models. Nat. Commun. 14, 4283 (2023).","journal-title":"Nat. Commun."},{"key":"63025_CR47","doi-asserted-by":"publisher","DOI":"10.1177\/1744806920950866","volume":"16","author":"H Viisanen","year":"2020","unstructured":"Viisanen, H. et al. Novel RET agonist for the treatment of experimental neuropathies. Mol. Pain. 16, 1744806920950866 (2020).","journal-title":"Mol. Pain."},{"key":"63025_CR48","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.3233\/JPD-202400","volume":"11","author":"JM Renko","year":"2021","unstructured":"Renko, J. M. et al. Neuroprotective Potential of a Small Molecule RET Agonist in Cultured Dopamine Neurons and Hemiparkinsonian Rats. J. Parkinsons Dis. 11, 1023\u20131046 (2021).","journal-title":"J. Parkinsons Dis."},{"key":"63025_CR49","doi-asserted-by":"publisher","first-page":"4348","DOI":"10.1021\/acs.biomac.2c00761","volume":"24","author":"MS Haider","year":"2023","unstructured":"Haider, M. S. et al. Biological activity in vitro, absorption, BBB penetration, and tolerability of nanoformulation of BT44:RET agonist with disease-modifying potential for the treatment of neurodegeneration. Biomacromolecules 24, 4348\u20134365 (2023).","journal-title":"Biomacromolecules"},{"key":"63025_CR50","doi-asserted-by":"publisher","first-page":"105429","DOI":"10.1016\/j.nbd.2021.105429","volume":"157","author":"L Andreoli","year":"2021","unstructured":"Andreoli, L., Abbaszadeh, M., Cao, X. & Cenci, M. A. Distinct patterns of dyskinetic and dystonic features following D1 or D2 receptor stimulation in a mouse model of Parkinsonism. Neurobiol. Dis. 157, 105429 (2021).","journal-title":"Neurobiol. Dis."},{"key":"63025_CR51","doi-asserted-by":"publisher","first-page":"273","DOI":"10.5607\/en20028","volume":"29","author":"JA Blosser","year":"2020","unstructured":"Blosser, J. A., Podolsky, E. & Lee, D. L-DOPA-induced dyskinesia in a genetic Drosophila model of Parkinson\u2019s disease. Exp. Neurobiol. 29, 273\u2013284 (2020).","journal-title":"Exp. Neurobiol."},{"key":"63025_CR52","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.nbd.2016.09.001","volume":"96","author":"I Sebastianutto","year":"2016","unstructured":"Sebastianutto, I., Maslava, N., Hopkins, C. R. & Cenci, M. A. Validation of an improved scale for rating l-DOPA-induced dyskinesia in the mouse and effects of specific dopamine receptor antagonists. Neurobiol. Dis. 96, 156\u2013170 (2016).","journal-title":"Neurobiol. Dis."},{"key":"63025_CR53","doi-asserted-by":"crossref","unstructured":"Barandas, M. et al. TSFEL: Time Series Feature Extraction Library. SoftwareX 11, 100456 (2020).","DOI":"10.1016\/j.softx.2020.100456"},{"key":"63025_CR54","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.jsv.2005.06.005","volume":"291","author":"BF Yan","year":"2006","unstructured":"Yan, B. F., Miyamoto, A. & Br\u00fchwiler, E. Wavelet transform-based modal parameter identification considering uncertainty. J. Sound Vib. 291, 285\u2013301 (2006).","journal-title":"J. Sound Vib."},{"key":"63025_CR55","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1109\/TAU.1967.1161901","volume":"15","author":"P Welch","year":"1967","unstructured":"Welch, P. The use of fast Fourier transform for the estimation of power spectra: A method based on time averaging over short, modified periodograms. IEEE Trans. Audio Electroacoust. 15, 70\u201373 (1967).","journal-title":"IEEE Trans. Audio Electroacoust."},{"key":"63025_CR56","unstructured":"Henriksson, U. Power Spectrum and Bandwidth. Tech. rep., Link\u00f6ping University, (2003)."},{"key":"63025_CR57","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1002\/mds.28215","volume":"35","author":"CW Olanow","year":"2020","unstructured":"Olanow, C. W., Calabresi, P. & Obeso, J. A. Continuous Dopaminergic stimulation as a treatment for Parkinson\u2019s disease: current status and future opportunities. Mov. Disord. 35, 1731\u20131744 (2020).","journal-title":"Mov. Disord."},{"key":"63025_CR58","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1038\/s41592-023-02122-4","volume":"21","author":"S Son","year":"2024","unstructured":"Son, S. et al. Real-time visualization of structural dynamics of synapses in live cells in vivo. Nat. Methods 21, 353\u2013360 (2024).","journal-title":"Nat. Methods"},{"key":"63025_CR59","doi-asserted-by":"publisher","first-page":"114011","DOI":"10.1016\/j.expneurol.2022.114011","volume":"352","author":"N Wenger","year":"2022","unstructured":"Wenger, N. et al. Rodent models for gait network disorders in Parkinson\u2019s disease - a translational perspective. Exp. Neurol. 352, 114011 (2022).","journal-title":"Exp. Neurol."},{"key":"63025_CR60","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.1038\/s41593-018-0209-y","volume":"21","author":"A Mathis","year":"2018","unstructured":"Mathis, A. et al. DeepLabCut: markerless pose estimation of user-defined body parts with deep learning. Nat. Neurosci. 21, 1281\u20131289 (2018).","journal-title":"Nat. Neurosci."},{"key":"63025_CR61","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1038\/s41592-018-0234-5","volume":"16","author":"TD Pereira","year":"2019","unstructured":"Pereira, T. D. et al. Fast animal pose estimation using deep neural networks. Nat. Methods 16, 117\u2013125 (2019).","journal-title":"Nat. Methods"},{"key":"63025_CR62","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1038\/s41593-020-00706-3","volume":"23","author":"AB Wiltschko","year":"2020","unstructured":"Wiltschko, A. B. et al. Revealing the structure of pharmacobehavioral space through motion sequencing. Nat. Neurosci. 23, 1433\u20131443 (2020).","journal-title":"Nat. Neurosci."},{"key":"63025_CR63","first-page":"55523","volume":"28","author":"CJ Miedel","year":"2017","unstructured":"Miedel, C. J., Patton, J. M., Miedel, A. N., Miedel, E. S. & Levenson, J. M. Assessment of spontaneous alternation, novel object recognition and limb clasping in transgenic mouse models of amyloid-beta and Tau neuropathology. J. Vis. Exp. 28, 55523 (2017).","journal-title":"J. Vis. Exp."},{"key":"63025_CR64","doi-asserted-by":"publisher","first-page":"4182","DOI":"10.1073\/pnas.0611625104","volume":"104","author":"I Gantois","year":"2007","unstructured":"Gantois, I. et al. Ablation of D1 dopamine receptor-expressing cells generates mice with seizures, dystonia, hyperactivity, and impaired oral behavior. Proc. Natl. Acad. Sci. USA 104, 4182\u20134187 (2007).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"63025_CR65","doi-asserted-by":"publisher","unstructured":"Alexey Bochkovskiy, C.-Y. W., Hong-Yuan Mark Liao YOLOv4: Optimal Speed and Accuracy of Object Detection. arXiv.2004.10934 https:\/\/doi.org\/10.48550\/arXiv.2004.10934 (2004).","DOI":"10.48550\/arXiv.2004.10934"},{"key":"63025_CR66","doi-asserted-by":"crossref","unstructured":"Richard Hartley, A. Z. Multiple View Geometry in Computer Vision (Cambridge University Press, 2004).","DOI":"10.1017\/CBO9780511811685"},{"key":"63025_CR67","unstructured":"Kwon, J. AVATARpy: Python analysis module for AVATAR recording system. AVATARpy version 0.1.9. GitHub repository https:\/\/github.com\/jeakwon\/avatarpy (2021)."},{"key":"63025_CR68","doi-asserted-by":"publisher","unstructured":"Kwon, J. et al. SUBTLE: An unsupervised platform with temporal link embedding that maps animal behavior. bioRxiv https:\/\/doi.org\/10.1101\/2023.04.12.536531 (2023).","DOI":"10.1101\/2023.04.12.536531"},{"key":"63025_CR69","doi-asserted-by":"publisher","unstructured":"Hyeon, B. et al. Dataset and code repository: Integrating artificial intelligence and optogenetics for Parkinson\u2019s disease diagnosis and therapeutics in male mice. https:\/\/doi.org\/10.6084\/m9.figshare.29840969. Figshare (2025).","DOI":"10.6084\/m9.figshare.29840969"}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63025-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63025-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63025-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T10:54:57Z","timestamp":1757415297000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-63025-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,21]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["63025"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-63025-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,21]]},"assertion":[{"value":"6 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"7797"}}